SYS-CON MEDIA Authors: Doug Masi, Mat Mathews, PR.com Newswire, David Smith, Tim Crawford

News Feed Item

DEKA Medical Receives FDA Clearance for the Synchro REPLA:Y

BRANFORD, Conn., Feb. 12, 2014 /PRNewswire/ -- DEKA Medical, Inc., a leading developer and distributor of a wide range of light-based aesthetic systems, today announced that it has recently received clearance from the FDA for its Synchro REPLA:Y®, an innovative aesthetic workstation dedicated, but not limited, to high speed stable long-term, or permanent hair reduction, treatment of PFB, treatment of benign pigmented lesions, treatment of wrinkles and photocoagulation of dermatological vascular lesions.

Powerful, Fast, Complete: the Synchro REPLA:Y by DEKA Medical combines hair removal on all Fitzpatrick skin types, including tanned skin, vascular and benign pigmented lesions treatments, as well as skin rejuvenation, in a single platform. Utilizing 3 different light sources: a 755 nm Alexandrite laser, a 1064 nm Nd:YAG laser and an intense pulsed light, the Synchro REPLA:Y represents an advancement in the field of aesthetics, enabling the discerning physician to offer a broad range of treatments with efficacy, speed and safety.

The Synchro REPLA:Y anticipates the future, including for the first time in one system one powerful (125 W) and fast (3 Hz, while the industry standard is still 2 Hz) Alexandrite laser, together with one powerful (150 W) and fast Nd:YAG laser with unrivaled characteristics. Both lasers feature a wide range of spot sizes: from 2.5 mm to 20 mm. The intense pulsed light features 5 filters (from 500 nm to 650 nm lower cut-off wavelength), easily interchangeable, to allow a broad range of effective and safe treatments.

Physicians worldwide agree that the Alexandrite and Nd:YAG wavelengths are the most efficacious for hair reduction treatments. While Alexandrite is universally recognized as the most effective laser source for hair reduction in fair skins, the Nd:YAG laser is the most widely used for treating dark skins. In addition, the the Synchro REPLA:Y's Alexandrite laser source can deliver energetic pulses with pulse length from 2 ms, down to 0.2 ms : another remarkable advantage for skin rejuvenation and pigmented lesions treatments, that makes the Synchro REPLA:Y a true high performance and unrivaled multi-wavelength workstation.

"The Synchro REPLA:Y is the fastest, most powerful laser, with one of the biggest spot sizes in the industry. The Synchro REPLA:Y's extreme versatility and the multiple hand pieces allow me to split the beam and the pulse to micro tune the treatment to each patient's needs. Due to the uniqueness of the pulse shape, the treatment, even at speed of 3 pulses per second, is less painful than the one I can deliver with other lasers and quite tolerable. I am thrilled to be the first hair removal specialist in North America to employ such a novel device in my business" said Chris Karavolas, President of New York State Association of Laser Hair Removal Specialists; Founding Board Member of the International Association of Laser Aesthetics (IALA); Owner of "Romeo & Juliette - Laser Hair Removal Center", New York, NY.

"As a double board certified Dermatologist, international educator and lecturer on lasers and energy based devices, it is my business to know about emerging technologies. At conferences around the world, during laser courses and even in my own office, I am constantly asked about various technologies. In searching for the very best devices for my own patients, I evaluate many variables, including safety and efficacy and the technical specifications are fairly important in the evaluation process, too. The Synchro REPLA:Y by DEKA offers 2 wavelengths and an intense pulsed light hand piece. The energies, varying pulse widths and pulse shape and the large (20 mm) spot sizes represent an advancement in technology, that results in faster, better tolerated and more reliable treatments. I am very excited to be the first Dermatologist in North America to use the Synchro REPLA:Y and to offer its benefits to my patients" said Martin Kassir M.D., F.A.A.D., Double Board Certified in Dermatology & Internal Medicine, Fellow ASLMS, Director of "Kassir Dermatology", Dallas, TX.

Both "Romeo & Juliette - Laser Hair Removal Center", New York, NY and "Kassir Dermatology", Dallas, TX are centers of excellence for Cutting Edge Aesthetics & DEKA Medical.

According to Millennium Research Group, Inc., the US combined demand for hair removal, pigmented lesion and vascular lesion removal is expected to increase 13.7 % from 2,111,400 treatments in 2013 to 2,445,900 treatments in 2014. The Synchro REPLA:Y is being distributed in North America exclusively by Cutting Edge Aesthetics, LLC, a wholly owned subsidiary of Cutting Edge Products, LLC. 

About Cutting Edge Products, LLC: Cutting Edge Products, LLC, based in Fairport, NY is a leading provider of light based technologies for a variety of markets within North America.  Founded in 2001, Cutting Edge has a long and established leadership position in the sales, distribution and support of laser systems in the orthopedic, podiatric, pain management and veterinary markets. Cutting Edge's newly forged partnership with DEKA Medical further expands Cutting Edge's vision of entering and growing within the aesthetics market.

About DEKA Medical, Inc.: DEKA Medical (www.dekamedinc.com) brings a selected range of medical and aesthetic devices, including the highly acclaimed SmartXide DOT, Synchro REPLA:Y, Synchro FT, Minsilk FT and a variety of surgical CO2 lasers, to the North American market. DEKA Medical provides advanced devices capable of delivering the highest standards in safety, reliability and consistency in the aesthetic and surgical arena. DEKA Medical is a Company of the El.En. Group (www.elengroup.com).

For more information on the product, please contact Cutting Edge Aesthetics at 800-889-4184, or visit www.dekamedinc.com

SOURCE Deka Medical

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.